Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.

Wester A, Devocelle M, Tallant EA, Chappell MC, Gallagher PE, Paradisi F.

Amino Acids. 2017 Oct;49(10):1733-1742. doi: 10.1007/s00726-017-2471-9. Epub 2017 Jul 25.

PMID:
28744580
2.

Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression.

Schaich CL, Grabenauer M, Thomas BF, Shaltout HA, Gallagher PE, Howlett AC, Diz DI.

Front Physiol. 2016 Jun 9;7:207. doi: 10.3389/fphys.2016.00207. eCollection 2016.

3.

Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation Therapy.

Willey JS, Bracey DN, Gallagher PE, Tallant EA, Wiggins WF, Callahan MF, Smith TL, Emory CL.

J Bone Joint Surg Am. 2016 Jan 6;98(1):48-55. doi: 10.2106/JBJS.O.00545.

PMID:
26738903
4.

Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies.

Yamaleyeva LM, Chappell MC, Brosnihan KB, Anton L, Caudell DL, Shi S, McGee C, Pirro N, Gallagher PE, Taylor RN, Merrill DC, Mertz HL.

Am J Physiol Endocrinol Metab. 2015 Nov 15;309(10):E852-60. doi: 10.1152/ajpendo.00272.2015. Epub 2015 Sep 22.

5.

Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity.

Schaich CL, Shaltout HA, Grabenauer M, Thomas BF, Gallagher PE, Howlett AC, Diz DI.

J Cardiovasc Pharmacol. 2015 May;65(5):473-9. doi: 10.1097/FJC.0000000000000216.

6.
7.

Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels.

Carver KA, Smith TL, Gallagher PE, Tallant EA.

Microcirculation. 2015 Jan;22(1):19-27. doi: 10.1111/micc.12159.

PMID:
25079175
8.

Angiotensin-(1-7): a peptide hormone with anti-cancer activity.

Gallagher PE, Arter AL, Deng G, Tallant EA.

Curr Med Chem. 2014;21(21):2417-23. Review.

PMID:
24524765
9.

Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling.

Moore ED, Kooshki M, Metheny-Barlow LJ, Gallagher PE, Robbins ME.

Free Radic Biol Med. 2013 Dec;65:1060-1068. doi: 10.1016/j.freeradbiomed.2013.08.183. Epub 2013 Sep 3.

10.

AT1, AT2, and AT(1-7) receptor expression in the uteroplacental unit of normotensive and hypertensive rats during early and late pregnancy.

Yamaleyeva LM, Neves LA, Coveleskie K, Diz DI, Gallagher PE, Brosnihan KB.

Placenta. 2013 Jun;34(6):497-502. doi: 10.1016/j.placenta.2013.03.008. Epub 2013 Apr 17.

11.

Brain renin-angiotensin system in the nexus of hypertension and aging.

Arnold AC, Gallagher PE, Diz DI.

Hypertens Res. 2013 Jan;36(1):5-13. doi: 10.1038/hr.2012.161. Epub 2012 Oct 18. Review.

12.

Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.

Nautiyal M, Katakam PV, Busija DW, Gallagher PE, Tallant EA, Chappell MC, Diz DI.

Am J Physiol Regul Integr Comp Physiol. 2012 Oct 15;303(8):R799-806. doi: 10.1152/ajpregu.00566.2011. Epub 2012 Aug 22.

13.

Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats.

Varagic J, Ahmad S, Voncannon JL, Moniwa N, Simington SW Jr, Brosnihan BK, Gallagher PE, Habibi J, Sowers JR, Ferrario CM.

J Hypertens. 2012 Sep;30(9):1766-74. doi: 10.1097/HJH.0b013e328356766f.

14.

Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.

Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, Tallant EA, Gallagher PE.

Prostate. 2013 Jan;73(1):71-82. doi: 10.1002/pros.22542. Epub 2012 May 29.

15.

Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.

Krishnan B, Torti FM, Gallagher PE, Tallant EA.

Prostate. 2013 Jan;73(1):60-70. doi: 10.1002/pros.22540. Epub 2012 May 29.

PMID:
22644934
16.

In vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mRen2)27 rats.

Garcia-Espinosa MA, Shaltout HA, Gallagher PE, Chappell MC, Diz DI.

J Cardiovasc Pharmacol. 2012 Aug;60(2):150-7. doi: 10.1097/FJC.0b013e3182588b32.

17.

Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.

Yamaleyeva LM, Lindsey SH, Varagic J, Zhang LL, Gallagher PE, Chen AF, Chappell MC.

J Cardiovasc Pharmacol. 2012 Jun;59(6):529-38. doi: 10.1097/FJC.0b013e31824dd15b.

18.

Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.

McCollum LT, Gallagher PE, Tallant EA.

Peptides. 2012 Apr;34(2):380-8. doi: 10.1016/j.peptides.2012.01.020. Epub 2012 Feb 2.

19.

Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.

McCollum LT, Gallagher PE, Ann Tallant E.

Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H801-10. doi: 10.1152/ajpheart.00908.2011. Epub 2011 Dec 2.

20.

Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat.

Lindsey SH, Yamaleyeva LM, Brosnihan KB, Gallagher PE, Chappell MC.

Hypertension. 2011 Oct;58(4):665-71. doi: 10.1161/HYPERTENSIONAHA.111.175174. Epub 2011 Aug 15.

21.

Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components.

Gilliam-Davis S, Gallagher PE, Payne VS, Kasper SO, Tommasi EN, Westwood BM, Robbins ME, Chappell MC, Diz DI.

Physiol Genomics. 2011 Jul 14;43(13):829-35. doi: 10.1152/physiolgenomics.00167.2010. Epub 2011 May 3.

22.

Angiotensin peptides and lung cancer.

Gallagher PE, Cook K, Soto-Pantoja D, Menon J, Tallant EA.

Curr Cancer Drug Targets. 2011 May;11(4):394-404. Review.

23.

Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.

Cook KL, Metheny-Barlow LJ, Tallant EA, Gallagher PE.

Cancer Res. 2010 Nov 1;70(21):8319-28. doi: 10.1158/0008-5472.CAN-10-1136. Epub 2010 Sep 13.

24.

Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain.

Cohen JA, Lindsey SH, Pirro NT, Brosnihan KB, Gallagher PE, Chappell MC.

Am J Physiol Renal Physiol. 2010 Jul;299(1):F35-42. doi: 10.1152/ajprenal.00138.2010. Epub 2010 May 12.

25.

Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.

Trask AJ, Groban L, Westwood BM, Varagic J, Ganten D, Gallagher PE, Chappell MC, Ferrario CM.

Am J Hypertens. 2010 Jun;23(6):687-93. doi: 10.1038/ajh.2010.51. Epub 2010 Mar 18.

26.

Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.

Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM.

Ther Adv Cardiovasc Dis. 2010 Feb;4(1):17-25. doi: 10.1177/1753944709353337. Epub 2009 Nov 27.

27.

Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.

Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM.

Clin Cancer Res. 2009 Dec 1;15(23):7398-404. doi: 10.1158/1078-0432.CCR-09-1957. Epub 2009 Nov 17.

28.

Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus.

Arnold AC, Shaltout HA, Gallagher PE, Diz DI.

Hypertension. 2009 Nov;54(5):1001-8. doi: 10.1161/HYPERTENSIONAHA.109.138065. Epub 2009 Sep 21.

29.

The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy.

Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB.

Endocrinology. 2009 Sep;150(9):4316-25. doi: 10.1210/en.2009-0076. Epub 2009 Jun 11.

30.

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.

Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA.

Mol Cancer Ther. 2009 Jun;8(6):1676-83. doi: 10.1158/1535-7163.MCT-09-0161. Epub 2009 Jun 9.

31.

The great contribution: Index Medicus, Index-Catalogue, and IndexCat.

Greenberg SJ, Gallagher PE.

J Med Libr Assoc. 2009 Apr;97(2):108-13. doi: 10.3163/1536-5050.97.2.007.

32.

Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.

Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC.

Endocrinology. 2009 Aug;150(8):3753-8. doi: 10.1210/en.2008-1664. Epub 2009 Apr 16.

33.

Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats.

Jessup JA, Brosnihan KB, Gallagher PE, Chappell MC, Ferrario CM.

J Am Soc Hypertens. 2008 Mar-Apr;2(2):106-15. doi: 10.1016/j.jash.2007.10.005.

34.

Regulation of ACE2 in cardiac myocytes and fibroblasts.

Gallagher PE, Ferrario CM, Tallant EA.

Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2373-9. doi: 10.1152/ajpheart.00426.2008. Epub 2008 Oct 10.

35.

MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.

Gallagher PE, Ferrario CM, Tallant EA.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1169-74. doi: 10.1152/ajpcell.00145.2008. Epub 2008 Sep 3.

36.

Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.

Diz DI, Garcia-Espinosa MA, Gallagher PE, Ganten D, Ferrario CM, Averill DB.

J Cardiovasc Pharmacol. 2008 Jun;51(6):542-8. doi: 10.1097/FJC.0b013e3181734a54.

37.

Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats.

Diz DI, Garcia-Espinosa MA, Gegick S, Tommasi EN, Ferrario CM, Ann Tallant E, Chappell MC, Gallagher PE.

Exp Physiol. 2008 May;93(5):694-700. doi: 10.1113/expphysiol.2007.040261. Epub 2008 Mar 20.

38.

Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.

Anton L, Merrill DC, Neves LA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB.

Hypertension. 2008 Apr;51(4):1066-72. doi: 10.1161/HYPERTENSIONAHA.107.103861. Epub 2008 Feb 7.

39.

ACE2 and ANG-(1-7) in the rat uterus during early and late gestation.

Neves LA, Stovall K, Joyner J, Vald├ęs G, Gallagher PE, Ferrario CM, Merrill DC, Brosnihan KB.

Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R151-61. Epub 2007 Oct 31.

40.

Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat.

Yamaleyeva LM, Pendergrass KD, Pirro NT, Gallagher PE, Groban L, Chappell MC.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2064-71. Epub 2007 Jul 13.

41.

Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.

Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE.

Cancer Res. 2007 Mar 15;67(6):2809-15.

42.

Baroreceptor reflex regulation in anesthetized transgenic rats with low glia-derived angiotensinogen.

Sakima A, Averill DB, Kasper SO, Jackson L, Ganten D, Ferrario CM, Gallagher PE, Diz DI.

Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1412-9. Epub 2006 Nov 3.

43.

Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2. Lewis rats.

Yamaleyeva LM, Gallagher PE, Vinsant S, Chappell MC.

Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R819-26. Epub 2006 Oct 5.

44.

Effect of estrogen on neprilysin expression in uterus and kidney of Sprague-Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats.

Neves LA, Chappell MC, Ferrario CM, Gallagher PE, Ganten D, Brosnihan KB.

Peptides. 2006 Nov;27(11):2912-8. Epub 2006 Aug 4.

PMID:
16890325
45.

Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.

Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1308-14. Epub 2006 Jun 20.

46.

Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.

Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2166-72. Epub 2006 Jun 9.

47.

Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart.

Tallant EA, Ferrario CM, Gallagher PE.

Future Cardiol. 2006 May;2(3):335-42. doi: 10.2217/14796678.2.3.335.

PMID:
19804091
48.

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.

Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.

Kidney Int. 2005 Nov;68(5):2189-96.

49.

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.

Gallagher PE, Chappell MC, Ferrario CM, Tallant EA.

Am J Physiol Cell Physiol. 2006 Feb;290(2):C420-6. Epub 2005 Sep 21.

50.

Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems.

Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI.

Physiol Genomics. 2005 Nov 17;23(3):311-7. Epub 2005 Aug 30.

PMID:
16131528

Supplemental Content

Loading ...
Support Center